Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Longeveron Inc. - Class A Common stock (LGVN)
Company Research
Source: Yahoo! Finance
Data from Phase 2a clinical trial evaluating Lomecel-B TM in Alzheimer's Disease selected for Featured Research Oral Presentation at 2024 Alzheimer's Association International Conference Completed two financings in April raising gross proceeds of $11.4 million to fund continued clinical development Focused expenditure management reduced first quarter Total Operating Expenses 8% year-over-year Company to host conference call and webcast today at 5:00pm ET MIAMI, May 14, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today reported financial results for the quarter ended March 31, 2024 and provided a business update. “In the first quarter, we continued to focus on advancing our cutting-edge cellular therapy research and its application through our investigational product candidate, Lomecel-B TM , in Hypoplastic Left He
Show less
Read more
Impact Snapshot
Event Time:
LGVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LGVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LGVN alerts
High impacting Longeveron Inc. - Class A Common stock news events
Weekly update
A roundup of the hottest topics
LGVN
News
- Longeveron® to Attend BIO International Convention 2024 [Yahoo! Finance]Yahoo! Finance
- Longeveron® to Attend BIO International Convention 2024GlobeNewswire
- Longeveron Inc. (NASDAQ: LGVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.MarketBeat
- Longeveron Announces First Quarter 2024 Financial Results and Provides Business UpdateGlobeNewswire
- Longeveron Announces Board of Directors Planned Transitions [Yahoo! Finance]Yahoo! Finance
LGVN
Earnings
- 5/14/24 - Beat
LGVN
Analyst Actions
- 5/17/24 - HC Wainwright
LGVN
Sec Filings
- 5/22/24 - Form 424B3
- 5/22/24 - Form EFFECT
- 5/21/24 - Form S-1/A
- LGVN's page on the SEC website